N2 CLINIC CELL ACT INC

About the salon

N2 CLINIC CELL ACT INC image
Salon: N2 CLINIC CELL ACT INC
Salon address: 6-6-5, Ginza 6-chome, Chuo-ku, Tokyo
Opeing hours: From Monday to Saturdays 10:00-18:30
Language: English, Japanese, Chinese
Accepted payments: Cash, VISA, MasterCard, American Express
Extras: Wifi
History of N2 Clinic
~ Aiming for the pinnacle of regenerative medicine ~
N2 Clinic was established in Daikanyama, Tokyo, in 2015.
At a time when regenerative medicine was not yet widely known to the general public,
we began our journey as a specialized clinic focused on stem cell and immune cell therapy,
with a clear vision: ‘The pursuit of true prevention and youthfulness based on science.
In 2024, Japan became the first country in the world to enact the Act on Ensuring the Safety of Regenerative Medicine, etc.
N2 Clinic was approved by the Ministry of Health, Labour and Welfare after undergoing rigorous screening.
We have earned trust as a provider of regenerative medicine that fully complies with the legal and regulatory framework.

Expanding our global presence to cater to the world’s elite.
To meet the growing demand both in Japan and abroad, we have entered the next stage of development.
* 2014: N2 Clinic Daikanyama opens for the first time in Daikanyama, Shibuya Ward, Tokyo
* 2021: Opening of N2 Clinic Hotel Chinzanso Tokyo in Hotel Chinzanso Tokyo, Chiyoda Ward, Tokyo
* 2022: Opened N2 Clinic Yotsuya in Yotsuya, Tokyo
* 2022 ─ N2 Clinic Vietnam opens as part of overseas expansion
* 2025: The Ginza Clinic will be relocated and expanded, and will reopen as N2 Clinic Ginza Main Branch, with a more sophisticated space and medical system.
With 10 years of trust and a proven track record, N2 Clinic will continue to support people around the world in achieving "true health and youth" as a leading regenerative medicine clinic in Asia.

Uncompromising standards for safety and effectiveness
All treatments are carried out after undergoing review by the Specific Certified Regenerative Medicine Committee certified by the Ministry of Health, Labor and Welfare, and obtaining a "Regenerative Medicine Provisional Plan Number."
Based on nationally approved protocols, we provide medical care with strict assurances of safety and effectiveness. We have established a system that allows patients to receive cutting-edge regenerative medicine with confidence and peace of mind.

Initiatives for medical collaboration and evidence building
* We have established a system that enables prompt collaboration with university and general hospitals in Tokyo when emergency testing or specialized treatment is required. This ability to quickly provide the most appropriate medical care in any situation offers patients greater peace of mind.
* We stay up to date with the latest clinical research both in Japan and abroad. By continuously monitoring new findings and conducting clinical studies within our clinic, we build a strong foundation of evidence. These insights are quickly reflected in our treatments, allowing us to maintain safe and effective medical protocols.

The utmost in cell culture quality
In regenerative medicine, the quality of the cells used in treatment and the reliability of the supporting technology are of utmost importance.
The cell culture supporting our treatment is conducted under strict quality control, in a sterile environment, and with high precision, in collaboration with the Biotherapy Research Institute, led by Chairman Dr. Yotsuya of N2 Clinic.
We provide an environment where each patient can receive treatment with peace of mind, guaranteeing the highest standards of safety and quality for all cellular products, meeting the expectations of our discerning clientele.
{{ $property->title }}の写真
{{ $property->title }}の写真
{{ $property->title }}の写真
{{ $property->title }}の写真
{{ $property->title }}の写真

Salon menus

Stylists

スタッフ画像

Shuichi Ishihara

Title Chief Doctor
Career 1985
Specialized in Stem Cell Therapy

Education:
1985 M.D. Kitasato University, School of Medicine
1992 PhD University of Texas, South Western Medical Center

Post Doctoral Training:

Internship;
1985 – 1987 Intern in General Surgery, Hibiya Hospital, Tokyo
1987 – 1988 Intern in Orthopedic Surgery, School of Medicine, Univ. of
Environmental and Health, Kyushu
1988 – 1991 Chief Resident of Dept. of Plastic and Reconstructive Surgery,
Kitasato Univ. Hospital.

Fellowships:
1991 – 1993 Fellow in Dept. of Cell Biology and Neuroscience, Dept. of
Emergency Center Burn Unit.
Univ. of Texas, South Western Medical Center at Dallas.
1993 – 1995 Fellow in Dept. of Emergency and Critical Center.
Kitasato Univ. Hospital
1995 – 1999 Assistant Professor, Dept. of Plastic and Reconstructive Surgery,
Kitasato Univ. School of Medicine.
1999 –Present Director of Advanced Aesthetic Institute (A.A.I.)
2014- Director A.A.I. Anti-Aging Center at Minamisoma Onoda Hospital.
Present

Licensure and Certification:
1985 Medical Doctor Japan
1992 Physiology Doctor Japan, U.S.A.
1991 Diplomat, Japanese Board of Plastic and Reconstructive Surgery
1997 Certificate of Obagi Skin Health Restoration
1999 Diplomat Japanese Board of Aesthetic Surgery
2003 Diplomat Society of Anti-Aging for physicians and Surgeons
Director of Japan

Nearby Salons

N2 CLINIC CELL ACT INC

N2 CLINIC CELL ACT INC

Clinic Ginza

History of N2 Clinic ~ Aiming for the pinnacle of regenerative medicine ~ N2 Clinic was established in Daikanyama, Tokyo, in 2015. At a time when regenerative medicine was not yet widely known to the general public, we began our journey as a specialized clinic focused on stem cell and immune cell therapy, with a clear vision: ‘The pursuit of true prevention and youthfulness based on science. In 2024, Japan became the first country in the world to enact the Act on Ensuring the Safety of Regenerative Medicine, etc. N2 Clinic was approved by the Ministry of Health, Labour and Welfare after undergoing rigorous screening. We have earned trust as a provider of regenerative medicine that fully complies with the legal and regulatory framework. Expanding our global presence to cater to the world’s elite. To meet the growing demand both in Japan and abroad, we have entered the next stage of development. * 2014: N2 Clinic Daikanyama opens for the first time in Daikanyama, Shibuya Ward, Tokyo * 2021: Opening of N2 Clinic Hotel Chinzanso Tokyo in Hotel Chinzanso Tokyo, Chiyoda Ward, Tokyo * 2022: Opened N2 Clinic Yotsuya in Yotsuya, Tokyo * 2022 ─ N2 Clinic Vietnam opens as part of overseas expansion * 2025: The Ginza Clinic will be relocated and expanded, and will reopen as N2 Clinic Ginza Main Branch, with a more sophisticated space and medical system. With 10 years of trust and a proven track record, N2 Clinic will continue to support people around the world in achieving "true health and youth" as a leading regenerative medicine clinic in Asia. Uncompromising standards for safety and effectiveness All treatments are carried out after undergoing review by the Specific Certified Regenerative Medicine Committee certified by the Ministry of Health, Labor and Welfare, and obtaining a "Regenerative Medicine Provisional Plan Number." Based on nationally approved protocols, we provide medical care with strict assurances of safety and effectiveness. We have established a system that allows patients to receive cutting-edge regenerative medicine with confidence and peace of mind. Initiatives for medical collaboration and evidence building * We have established a system that enables prompt collaboration with university and general hospitals in Tokyo when emergency testing or specialized treatment is required. This ability to quickly provide the most appropriate medical care in any situation offers patients greater peace of mind. * We stay up to date with the latest clinical research both in Japan and abroad. By continuously monitoring new findings and conducting clinical studies within our clinic, we build a strong foundation of evidence. These insights are quickly reflected in our treatments, allowing us to maintain safe and effective medical protocols. The utmost in cell culture quality In regenerative medicine, the quality of the cells used in treatment and the reliability of the supporting technology are of utmost importance. The cell culture supporting our treatment is conducted under strict quality control, in a sterile environment, and with high precision, in collaboration with the Biotherapy Research Institute, led by Chairman Dr. Yotsuya of N2 Clinic. We provide an environment where each patient can receive treatment with peace of mind, guaranteeing the highest standards of safety and quality for all cellular products, meeting the expectations of our discerning clientele.

> More

Reviews

No reviews yet.